The Path to IND: Roadblocks, Milestones, and Success Stories
Join Nuventra Pharma Sciences to learn how to successfully navigate the FDA’s Investigational New Drug (IND) program to start human clinical trials.
For entrepreneurs engaged in drug discovery, few things are as important as successfully navigating the FDA’s Investigational New Drug (IND) program to start human clinical trials. That’s why planning is essential to gather the data that FDA and investors see as important.
Join Nuventra’s CEO, Geoff Banks, Ph.D., and Senior Consultants, Todd Shearer, Ph.D. and Mark Bush, Ph.D., to learn key clinical pharmacology strategies to use on your path to IND. The second half of this session will feature a panel discussion. You’ll hear from Paul Feldman, Head of Discovery and Translational Medicine at Intarcia Therapeutics, Inc. and Lini Pandite, M.D., Chief Medical Officerr at Shattuck Labs, who will share their experience and provide some tips on the process.
The event is free – register in advance here.
About LaunchBio’s Larger Than Life Science Series:
Come for the people and programs. Stay for a beer. Leave with your next big breakthrough.
Larger Than Life Science is a free monthly event series open to everyone interested in building a strong support network for North Carolina’s life science and healthcare innovators.
Larger Than Life Science is held in the atrium level of the newly renovated Chesterfield Building in downtown Durham from 4-7 p.m. the first Thursday of each month. Join us for an evening of unconventional conversation!